This invention relates to compositions and medical devices comprising anti-microbial active particles, for inhibiting microbial growth. This invention further provides methods of making such compositions and medical devices.

This invention relates to compositions and medical devices comprising anti-microbial active particles, for inhibiting microbial growth. This invention further provides methods of making such compositions and medical devices.

The present invention relates to a method for producing a cationic polyvinyl amine based copolymer. The present invention further relates to a cationic polyvinyl amine based copolymer and use of the copolymer in paper industry as a strength agent, a retention agent and a drainage agent.

A method of improving dry strength and/or drainage of a paper or paperboard by adding to a paper or paperboard furnish, a graft copolymer composition of a vinyl monomer and a functionalized vinylamine-containing base polymer graft copolymer.

A method of improving dry strength and/or drainage of a paper or paperboard by adding to a paper or paperboard furnish, a graft copolymer composition of a vinyl monomer and a functionalized vinylamine-containing base polymer graft copolymer.

A method of improving dry strength and/or drainage of a paper or paperboard by adding to a paper or paperboard furnish, a graft copolymer composition of a vinyl monomer and a functionalized vinylamine-containing base polymer graft copolymer.

This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.

This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.

The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.

The disclosure relates to cationic polymers functionalized with substituted phenylboronic acid groups and to methods of using the same to treat metabolic and gastrointestinal disorders.